So Young Medical Apologizes to Ma Sichun, Initiates Internal Review and Accountability

Deep News
06/12

On the evening of June 12th, So Young Medical issued a statement on social media, offering a formal apology to actress Ma Sichun, her family, her fans, and the general public regarding a recent article with a highly inappropriate title.

The company explained that on June 11th, its official WeChat public account published an article titled "Ma Sichun, Died at Age 37." The title was derived from a segment in a previous public interview where Ma Sichun discussed writing her own obituary as a life reflection exercise. However, the title was taken out of context and used severely inappropriate wording, creating ambiguity and causing serious offense to Ma Sichun and her family, as well as alarming and misleading her fans and the wider online community.

So Young expressed its sincere apologies to Ma Sichun, her family, and her fans, and to all those disturbed by the headline. The company acknowledged that the publication of such an improper title exposed flaws in its review process, with primary responsibility lying with management.

The company outlined the actions it has taken and will continue to implement. First, the offending article was immediately removed, and a review of all historical content across its platforms has been conducted. Second, a comprehensive upgrade of the multi-level review mechanism for titles and content is underway. Third, an internal review and accountability process has been initiated.

So Young stated that Ma Sichun's candid sharing of her reflections on life in that interview deserved to be treated with seriousness and respect, and the headline failed to do so, which is the core issue requiring reflection. The company reiterated its apology.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10